Propeller Health is partnering with Aptar Pharma, a drug delivery system company, to create what the company believes will be the first-to-market integrated, connected metered dose inhaler (MDI).
"Patients and physicians deserve better designed inhalers that are easier to use and help them successfully treat their chronic respiratory disease,” David Van Sickle, CEO of Propeller, said in a...
LifeMap Solutions, the San Jose-California startup behind the ResearchKit app Asthma Health, has launched its second app, COPD Navigator, for free in the app store. At the same time, the company has launched a branded, enterprise version of COPD Navigator, called iBreathe, with chronic care management company SuperCare Health.
Both versions of the app will provide local weather and air quality...
Over the last two years, big pharma has gotten behind the idea of smartphone-connected inhalers for asthma and COPD in a big way. Two acquisitions, a $3 million investment, and a number of pilot and partnership deals have shown clearly that the space is of interest. (MobiHealthNews is helping to put on two pharma-related events at the mHealth Summit next week -- be sure to join us if you'll be in...
Adherium, the Australian connected inhaler company that partnered with AstraZeneca earlier this summer, has released data from three small studies of the company's Smartinhaler system. Data from the studies, all of which involved children and adolescents, indicate a 144 percent increase in adherence for patients using the connected devices, a 14.9 percent increase in lung function and a 37...
Teva Pharmaceuticals will acquire Cambridge, Massachusetts-based Gecko Health Innovations (previously known as GeckoCap), a smart inhaler company. The terms of the deal were not disclosed.
Gecko's main product is CareTRx a platform for chronic respiratory disease management that combines a sensor device that connects to most inhalers, a data analytics platform, an accessible user interface, and...
AstraZeneca has partnered with New Zealand-based Adherium Limited, which offers a mobile-enabled inhaler, to incorporate digital health offerings into AstraZeneca’s patient support programs for people with COPD and asthma.
Adherium's Smartinhaler sends data on when medication was taken to mobile devices and desktop computers via Bluetooth. The platform is designed to help patients, caregivers,...
Madison, Wisconsin-based Propeller Health has secured two new FDA clearances for new sensors that are designed to work with two particular inhalers on the market: the Diskus inhaler from GlaxoSmithKline and the Respimat inhaler from Boehringer Ingelheim. Unlike previous FDA clearances for Propeller, the new clearances actually allow Propeller to market its new devices as improving — not just...
Pharma-related digital health news picked up this week. Boehringer Ingelheim has teamed up with Sutter Health to research COPD interventions; BioDelivery Science created an app to help users deal with prediction opioid addictions; and Canaan Partners' Julie Papanek talked to the Wall Street Journal about pharma's emerging role in digital health.
Boehringer Ingelheim Pharmaceuticals, the...
Aliso Viego, California-based Sentrian, the remote patient monitoring company formerly known as Jointly Health, will work with Scripps Translational Science Institute to study its technology on 2,000 patients with COPD. All the patients are members of CareMore, an Anthem subsidiary that focuses on elderly patients and connected care.
The Sentrian Remote Patient Intelligence platform uses...
LifeMap Solutions, the San Jose, California-based company that recently collaborated with Apple on one of the flagship apps for Apple ResearchKit, has launched a new pilot with Mount Sinai Hospital in New York. LifeMap will team up with Mount Sinai's Icahn School of Medicine and the National Jewish Health Respiratory Institute (NJHRI) to develop a COPD platform that includes both a mobile app and...
